Page 112 - MemoriaER-Eng
P. 112
RESEARCH GROUPS
é
ú
ñ
ò
PROGRAMME:
Group U722
Mitochondrial Medicine
òLead Researcher
Cardellach López, Francesc
Group Members
Contact:
STAFF MEMBERS
Garrabou Tornos, Glria
Hospital Clinic de Barcelona (HCB)
Contact: Glria Garrabou / Constanza Morén Morn Nez, Constanza*
c/ Villarroel, 170. Barcelona · Phone: (+34) 93 227 54 00
ASSOCIATED MEMBERS
E.mail: [email protected] Grau Junyent, Josep Ma
http://www.idibaps.org/recerca/704/recerca-muscular-i-funcio-mitocondrial
Main lines of research
• Creation of the Group for Medical Assistance of Adult Patients with Rare
Diseases (basically of metabolic and mitochondrial origen, among others).
• Mitochondrial Pathology: Mitochondrial basis of disease and cell processes.
• Muscular Pathology (mitochondrial, inflammatory, autoinmune and toxic).
• Toxicity induced by drugs that cause clinic manifestations of mitochondrial
origen (Lipodystrophy, hyperlactatemia, peripheral neuropathy, infertility,
obstetric problems, miopathy.)
13
20
• T
Toxicity induced by tobacco and carbon monoxide that cause clinic manifes- R
tations of mitochondrial origen.
PO
E
• Mitochondrial basis of Parkinson disease associated to mutations in Parkin L R
A
and LRRK2 genes (rare forms of the disease).
NU
N
• Mitochondrial basis of body inclusion myositis. A
/
• Mitochondrial function in the study of gene therapy in MNGIE. ER
ER
• Mitochondrial implication in X-Fragile Syndrome. B
CI
• Mitochondrial basis on intrauterine growth restriction.
112
* At the expense of Project
